Literature DB >> 20454904

[Glaucoma and cataract].

T H Klink1, M Müller, M Zierhut, G Geerling.   

Abstract

The coincidence of cataract and glaucoma is increasing due to population development. Trabeculectomy is still the most commonly used procedure in combined glaucoma-cataract surgery. However, a two-step approach, starting with cataract surgery should be preferred to minimize the risk of secondary filtering bleb scarring. Postoperative fibrin exudation and the complication rate are more pronounced after combined trabeculectomy compared to combined trabeculotomy and non-penetrating glaucoma surgery. Canaloplasty is a new innovative non-penetrating glaucoma procedure. The results after canaloplasty show an even lower intraocular pressure (IOP) after combined procedures compared to canaloplasty alone. Long-term results have to confirm a sustained decrease of IOP. Surgery of the chamber angle combined with cataract surgery has hardly any complications and preserves the conjunctiva. It also allows medication to be saved and more invasive surgery to be postponed.

Entities:  

Mesh:

Year:  2010        PMID: 20454904     DOI: 10.1007/s00347-009-2062-6

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  32 in total

1.  Viscocanalostomy and phacoviscocanalostomy: long-term results.

Authors:  Manjieh S Wishart; Tejpal Shergill; Hamid Porooshani
Journal:  J Cataract Refract Surg       Date:  2002-05       Impact factor: 3.351

2.  Combined cataract extraction and trabeculotomy by the internal approach for coexisting cataract and open-angle glaucoma: initial results.

Authors:  Brian A Francis; Don Minckler; Laurie Dustin; Shahem Kawji; Jason Yeh; Arthur Sit; Sameh Mosaed; Murray Johnstone
Journal:  J Cataract Refract Surg       Date:  2008-07       Impact factor: 3.351

3.  A prospective randomized comparison of two techniques of combined cataract-glaucoma surgery.

Authors:  J Borggrefe; W Lieb; F Grehn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1999-11       Impact factor: 3.117

4.  Phacotrabeculectomy versus two-stage operation: a matched study.

Authors:  F F El-Sayyad; M H Helal; M M Khalil; M A El-Maghraby
Journal:  Ophthalmic Surg Lasers       Date:  1999-04

5.  Comparative study of trabecular aspiration vs trabeculectomy in glaucoma triple procedure to treat pseudoexfoliation glaucoma.

Authors:  P C Jacobi; T S Dietlein; G K Krieglstein
Journal:  Arch Ophthalmol       Date:  1999-10

6.  Long-term results of cataract surgery combined with trabeculotomy.

Authors:  Esther Hoffmann; Oliver Schwenn; Matthias Karallus; Frank Krummenauer; Franz Grehn; Norbert Pfeiffer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2002-01       Impact factor: 3.117

7.  Coexistent primary open-angle glaucoma and cataract: interim analysis of a trabecular micro-bypass stent and concurrent cataract surgery.

Authors:  Detlev Spiegel; Wolfgang Wetzel; Thomas Neuhann; Jorg Stuermer; Helmut Hoeh; Julian Garcia-Feijoo; José Maria Martinez-De-La-Casa; Julian Garcia-Sanchez
Journal:  Eur J Ophthalmol       Date:  2009 May-Jun       Impact factor: 2.597

8.  Phacoemulsification in patients with previous trabeculectomy: role of 5-fluorouracil.

Authors:  T K Sharma; S Arora; P G Corridan
Journal:  Eye (Lond)       Date:  2006-03-17       Impact factor: 3.775

Review 9.  Surgical strategies for coexisting glaucoma and cataract: an evidence-based update.

Authors:  David S Friedman; Henry D Jampel; Lisa H Lubomski; John H Kempen; Harry Quigley; Nathan Congdon; Hani Levkovitch-Verbin; Karen A Robinson; Eric B Bass
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

10.  Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes.

Authors:  Sanjay K Murthy; Karim F Damji; Yi Pan; William G Hodge
Journal:  Can J Ophthalmol       Date:  2006-02       Impact factor: 1.882

View more
  1 in total

1.  [Modern filtration surgery. An update].

Authors:  T Klink; F Grehn
Journal:  Ophthalmologe       Date:  2013-04       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.